Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 74.98

-1.9%

Nov 20 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1596)	3/14/2006 11:18:37 AM
From: Jibacoa	Read Replies (1) of 3722

NVAX Also made a 52wks. H an opened with an upgap.<g> bigcharts.marketwatch.com An analyst at R&R said yesterday that NVAX vaccine development operations have been "outstanding" and raised his "target" to $10.<g> The HHS said that the US plans to spend around $1.78B on developing bird flu vaccines & NVAX's vaccine is ranked as "the best".<g> bigcharts.marketwatch.com With some further "news" the stock could get to test the resistance at $8 <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next